CSIR-NIIST introduces new tech for biomedical waste safety
WATER & WASTE

CSIR-NIIST introduces new tech for biomedical waste safety

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country.

This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26.

As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing.

Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste.

Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, "This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration."

Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source.

However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board.

"CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept," he had added.

Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country. This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26. As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing. Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste. Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration. Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source. However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board. CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept, he had added. Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

Next Story
Infrastructure Urban

Macrotech acquires Bain Capital's stake in 3 entities for Rs 3 Bn

Realty firm Macrotech Developers has acquired Bain Capital's stake in three industrial and logistics park entities for Rs 3.07 billion as part of a strategy to enhance rental income. Macrotech Developers is one of the leading real estate firms in the country. It sells properties under Lodha brand. In a regulatory filing, the company informed that it has "executed Securities Purchase Agreements (SPAs) with India Opportunities Fund SSA Scheme 1 and DSS Opportunities Investment 1 (Bain Capital) for acquisition of their interest in the digital infrastructure platform entities (Bellissimo Digital I..

Next Story
Infrastructure Urban

Tata Steel reports Rs 7.59 Bn net profit in Jul-Sep

Tata Steel reported a net profit of Rs 7.58 billion for the September 2024 quarter, helped by lower expenses. It had posted a net loss of Rs 65.11 billion in the July-September period of the preceding 2023-24 fiscal, the company said in an exchange filing. In a separate statement, Tata Steel CEO and MD TV Narendran said the global operating environment remained complex, with key regions facing subdued growth. Macroeconomic conditions in China continued to weigh on commodity prices, including steel. In India, steel demand continued to improve, but domestic prices were under pressure due to chea..

Next Story
Infrastructure Urban

SC to verdict on Nov 7 on plea against NCLAT

The Supreme Court is scheduled to pronounce its verdict on a plea of State Bank of India (SBI) and other creditors challenging the National Company Law Appellate Tribunal (NCLAT) decision that upheld the resolution plan of grounded air carrier Jet Airways and approved the transfer of its ownership to Jalan Kalrock Consortium (JKC). A bench of Chief Justice D Y Chandrachud and Justices J B Pardiwala and Manoj Misra will pronounce the verdict which was reserved on October 16. The NCLAT had on March 12 upheld the resolution plan of the grounded air carrier and approved the transfer of its ownersh..

Hi There!

"Now get regular updates from CW Magazine on WhatsApp!

Join the CW WhatsApp channel for the latest news, industry events, expert insights, and project updates from the construction and infrastructure industry.

Click the link below to join"

+91 81086 03000